Turkey: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Turkey

The Turkish medicaments containing hormones market reached $X in 2022, growing by X% against the previous year. In general, consumption showed a remarkable increase. Medicaments containing hormones consumption peaked at $X in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Medicaments Containing Hormones Production in Turkey

In value terms, medicaments containing hormones production totaled $X in 2022 estimated in export price. Over the period under review, production recorded a strong increase. The growth pace was the most rapid in 2014 when the production volume increased by X% against the previous year. Over the period under review, production attained the maximum level at $X in 2017; however, from 2018 to 2022, production failed to regain momentum.

Medicaments Containing Hormones Exports

Exports from Turkey

Medicaments containing hormones exports from Turkey reduced sharply to X tons in 2022, which is down by X% on 2021 figures. In general, exports, however, showed significant growth. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. Over the period under review, the exports hit record highs at X tons in 2020; however, from 2021 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing hormones exports dropped significantly to $X in 2022. Overall, exports, however, showed a significant expansion. The pace of growth appeared the most rapid in 2013 when exports increased by X% against the previous year. Over the period under review, the exports reached the peak figure at $X in 2021, and then declined markedly in the following year.

Exports by Country

Syrian Arab Republic (X tons) was the main destination for medicaments containing hormones exports from Turkey, accounting for a X% share of total exports. Moreover, medicaments containing hormones exports to Syrian Arab Republic exceeded the volume sent to the second major destination, Iraq (X tons), threefold.

From 2012 to 2022, the average annual growth rate of volume to Syrian Arab Republic stood at X%.

In value terms, Syrian Arab Republic ($X) remains the key foreign market for medicaments containing hormones but not antibiotics exports from Turkey, comprising X% of total exports. The second position in the ranking was held by Iraq ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value to Syrian Arab Republic amounted to X%.

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, dropping by X% against the previous year. Overall, the export price continues to indicate a abrupt decline. The most prominent rate of growth was recorded in 2015 when the average export price increased by X% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the average export prices remained at a lower figure.

Average prices varied noticeably for the major export markets. In 2022, amid the top suppliers, the country with the highest price was Syrian Arab Republic ($X per ton), while the average price for exports to Iraq totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Cyprus (X%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Hormones Imports

Imports into Turkey

In 2022, supplies from abroad of medicaments containing hormones but not antibiotics was finally on the rise to reach X tons after two years of decline. Overall, imports, however, saw a perceptible setback. The pace of growth was the most pronounced in 2017 when imports increased by X%. Over the period under review, imports reached the maximum at X tons in 2012; however, from 2013 to 2022, imports failed to regain momentum.

In value terms, medicaments containing hormones imports soared to $X in 2022. Over the period under review, imports showed a strong expansion. The pace of growth was the most pronounced in 2019 with an increase of X%. Imports peaked in 2022 and are expected to retain growth in years to come.

Imports by Country

The Netherlands (X tons), Italy (X tons) and South Korea (X tons) were the main suppliers of medicaments containing hormones imports to Turkey, together comprising X% of total imports.

From 2012 to 2022, the biggest increases were recorded for the Netherlands (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Turkey, comprising X% of total imports. The second position in the ranking was held by South Korea ($X), with a X% share of total imports. It was followed by Italy, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the Netherlands stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: South Korea (X% per year) and Italy (X% per year).

Import Prices by Country

In 2022, the average medicaments containing hormones import price amounted to $X per ton, shrinking by X% against the previous year. Over the period under review, the import price, however, enjoyed a resilient expansion. The pace of growth was the most pronounced in 2014 when the average import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton. From 2015 to 2022, the average import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the Netherlands ($X per ton), while the price for Italy ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :